Last reviewed · How we verify
D797
At a glance
| Generic name | D797 |
|---|---|
| Sponsor | Chong Kun Dang Pharmaceutical |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-355 (PHASE1)
- CKD-355 Drug-drug Interaction Study (CKD-355 DDI P1) (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- D797 CI brief — competitive landscape report
- D797 updates RSS · CI watch RSS
- Chong Kun Dang Pharmaceutical portfolio CI